Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
TEVA PHARMACEUTICALS USA, INC. v. AMGEN INC.
Case Number:
2:09-cv-05675
Court:
Nature of Suit:
Judge:
Firms
Companies
Sectors & Industries:
-
July 15, 2011
Amgen, Teva Settle Patent Suit Over Neopogen Generic
A Pennsylvania federal judge on Friday approved a settlement between generics maker Teva Pharmaceuticals USA Inc. and Amgen Inc. that squashes Teva's hopes of marketing a copycat version of the blood drug Neopogen until 2013.
-
November 22, 2010
Amgen Loses Bid To Wrap Up Teva Patent Fight
Pharmaceutical giant Amgen Inc. has lost its bid for partial summary judgment in a patent spat launched by Teva Pharmaceuticals USA Inc. as part of its effort to market a generic version of Amgen's blood drug Neupogen.